Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

MD Muenter

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Dominant Genes

Activities & Behaviors

Activities of Daily Living

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Singleton A B; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson M R; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
alpha-Synuclein locus triplication causes Parkinson's disease.
Wszolek Z K; Gwinn-Hardy K; Wszolek E K; Muenter M D; Pfeiffer R F; Rodnitzky R L; Uitti R J; McComb R D; Gasser T; Dickson D W
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.
Gwinn-Hardy K; Mehta N D; Farrer M; Maraganore D; Muenter M; Yen S H; Hardy J; Dickson D W
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of MD Muenter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2003: Singleton A B; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson M R; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
alpha-Synuclein locus triplication causes Parkinson's disease.
Science (New York, N.Y.) 2003;302(5646):841.
2002: Wszolek Z K; Gwinn-Hardy K; Wszolek E K; Muenter M D; Pfeiffer R F; Rodnitzky R L; Uitti R J; McComb R D; Gasser T; Dickson D W
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.
Acta neuropathologica 2002;103(4):344-50.
2000: Gwinn-Hardy K; Mehta N D; Farrer M; Maraganore D; Muenter M; Yen S H; Hardy J; Dickson D W
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.
Acta neuropathologica 2000;99(6):663-72.
2000: Caviness J N; Smith B E; Stevens J C; Adler C H; Caselli R J; Reiners C A; Hentz J G; Muenter M D
Motor unit changes in sporadic idiopathic Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):238-43.
2000: Caviness J N; Gwinn-Hardy K; Adler C H; Muenter M D
Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):140-5.
1999: Gwinn-Hardy K; Evidente V G; Waters C; Muenter M D; Hardy J
L-dopa slows the progression of familial parkinsonism.
Lancet 1999;353(9167):1850-1.
1999: Farrer M; Gwinn-Hardy K; Muenter M; DeVrieze F W; Crook R; Perez-Tur J; Lincoln S; Maraganore D; Adler C; Newman S; MacElwee K; McCarthy P; Miller C; Waters C; Hardy J
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor.
Human molecular genetics 1999;8(1):81-5.
1998: Dewey R B; Muenter M D; Kishore A; Snow B J
Long-term follow-up of levodopa responsiveness in generalized dystonia.
Archives of neurology 1998;55(10):1320-3.
1998: Muenter M D; Forno L S; Hornykiewicz O; Kish S J; Maraganore D M; Caselli R J; Okazaki H; Howard F M; Snow B J; Calne D B
Hereditary form of parkinsonism--dementia.
Annals of neurology 1998;43(6):768-81.
1998: Caviness J N; Adler C H; Newman S; Caselli R J; Muenter M D
Cortical myoclonus in levodopa-responsive parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):540-4.
1998: Hardy J; Pérez-Tur J; Baker M; Farrer M; Crook R; Hutton M; Johnson W G; Gwinn K; Muenter M; Rocca W A; Maraganore D
Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism.
American journal of medical genetics 1998;81(2):166-71.
1998: Evidente V G; Gwinn K A; Caviness J N; Muenter M; Mulder D W
Early cinematographic cases of postencephalitic parkinsonism and other movement disorders.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):167-9.
1996: Ahlskog J E; Wright K F; Muenter M D; Adler C H
Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.
Clinical neuropharmacology 1996;19(3):202-12.
1996: Hutton J T; Koller W C; Ahlskog J E; Pahwa R; Hurtig H I; Stern M B; Hiner B C; Lieberman A; Pfeiffer R F; Rodnitzky R L; Waters C H; Muenter M D; Adler C H; Morris J L
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
Neurology 1996;46(4):1062-5.
1994: Ahlskog J E; Muenter M D; Maraganore D M; Matsumoto J Y; Lieberman A; Wright K F; Wheeler K
Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.
Archives of neurology 1994;51(12):1236-41.
1993: Uitti R J; Ahlskog J E; Maraganore D M; Muenter M D; Atkinson E J; Cha R H; O'Brien P C
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.
Neurology 1993;43(10):1918-26.
1993: Lieberman A; Imke S; Muenter M; Wheeler K; Ahlskog J E; Matsumoto J Y; Maraganore D M; Wright K F; Schoenfelder J
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.
Neurology 1993;43(10):1981-4.
1992: Ahlskog J E; Muenter M D; Bailey P A; Stevens P M
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)
Archives of neurology 1992;49(5):560-8.
1991: Muenter M D; Daube J R; Caviness J N; Miller P M
Treatment of essential tremor with methazolamide.
Mayo Clinic proceedings. Mayo Clinic 1991;66(10):991-7.
1991: Ahlskog J E; Muenter M D; Bailey P A; Miller P M
Parkinson's disease monotherapy with controlled-release MK-458 (PHNO): double-blind study and comparison to carbidopa/levodopa.
Clinical neuropharmacology 1991;14(3):214-27.
1991: Caviness J N; Muenter M D
An unusual cause of recurrent chorea.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):355-7.
1988: Ahlskog J E; Muenter M D
Pergolide: long-term use in Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1988;63(10):979-87.
1988: Ahlskog J E; Muenter M D
Treatment of Parkinson's disease with pergolide: a double-blind study.
Mayo Clinic proceedings. Mayo Clinic 1988;63(10):969-78.
1988: Muenter M D; Ahlskog J E; Bell G; McManis P
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent.
Neurology 1988;38(10):1541-5.
1988: Ahlskog J E; Muenter M D; McManis P G; Bell G N; Bailey P A
Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
Mayo Clinic proceedings. Mayo Clinic 1988;63(9):876-86.
1988: Golbe L I; Lieberman A N; Muenter M D; Ahlskog J E; Gopinathan G; Neophytides A N; Foo S H; Duvoisin R C
Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease.
Clinical neuropharmacology 1988;11(1):45-55.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

MD Muenter

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of MD Muenter (preview)

All Publications